default author photo

Xiaoling Xu

University of Science and Technology of China (USTC) - Department of Pulmonary and Critical Care Medicine

Hefei

China

SCHOLARLY PAPERS

2

DOWNLOADS

565

TOTAL CITATIONS

9

Scholarly Papers (2)

1.

Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter Trial

Number of pages: 19 Posted: 29 Aug 2020
Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China (USTC) - Division of Molecular Medicine, Drug Clinical Trail Institution, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Huazhong University of Science and Technology - Department of Infectious Diseases, Fuyang 2nd People’s Hospital - Department of Internal Medicine, Hunan Provincial Clinical Research Center for Respiratory Disease, ntensive Care Unit, The First Affiliated Hospital of University of Science and Technology of China, Intensive Care Unit, the First Affiliated Hospital of University of Science and Technology of China, u'an people's Hospital affiliated to Anhui Medical University, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Bengbu Medical College, Clinical Research Center for Respiratory Disease, Anhui Medical University - Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China, Department of Endocrinology, the First Affiliated Hospital of University of Science and Technology of China, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, Department of Oncology, the First Affiliated Hospital of University of Science and Technology of China, Department of Endocrinology, the First Affiliated Hospital of University of Science and Technology of China, Department of Endocrinology, the First Affiliated Hospital of University of Science and Technology of China, Department of Hematology, the First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Intensive Care Unit, the First Affiliated Hospital of University of Science and Technology of China, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China (USTC) - Division of Molecular Medicine, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China and University of Science and Technology of China (USTC) - Department of Pulmonary and Critical Care Medicine
Downloads 490 (144,058)
Citation 9

Abstract:

Loading...

Tocilizumab, Covid-19, cytokine storm

2.

High Efficacy of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Adult Tuberculosis: A Phase III, Multi-Centered, Double-Blind, Hospital-Based, Randomized Controlled Trial

Number of pages: 18 Posted: 25 Jul 2022
Fudan University - Shanghai Public Health Clinical Center, Government of the People's Republic of China - National Institutes for Food and Drug Control, Fudan University - Shanghai Public Health Clinical Center, Fudan University - Shanghai Public Health Clinical Center, Fudan University - Shanghai Public Health Clinical Center, Wuhan Institute for Tuberculosis Control - Department of Respiratory and Critical Care Medicine Ward 1, Tianjin University, Chongqing Medical University - First Affiliated Hospital, Fuzhou Pulmonary Hospital of Fujian, Fifth People’s Hospital of Wuxi, Capital Medical University - Beijing Chest Hospital, Third People’s Hospital of Zhenjiang, Third People's Hospital of Shenzhen - National Clinical Research Center for Infectious Diseases, University of Science and Technology of China (USTC) - Department of Pulmonary and Critical Care Medicine, Third People's Hospital of Shenzhen - National Clinical Research Center for Infectious Diseases, Third People's Hospital of Shenzhen - National Clinical Research Center for Infectious Diseases, Government of the People's Republic of China - National Institutes for Food and Drug Control and Fudan University - Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS)
Downloads 75 (837,727)

Abstract:

Loading...

Tuberculosis, skin test, ESAT6-CFP10, clinical trial, diagnosis